Cargando…

Central Nervous System Involvement in ANCA-Associated Vasculitis: What Neurologists Need to Know

Objective: To provide a comprehensive review of the central nervous system (CNS) involvement in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), including the pathogenesis, clinical manifestations, ancillary investigations, differential diagnosis, and treatment. Particular em...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yang, Zhang, Yinxi, Cai, Mengting, Lai, Nanxi, Chen, Zhong, Ding, Meiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335277/
https://www.ncbi.nlm.nih.gov/pubmed/30687221
http://dx.doi.org/10.3389/fneur.2018.01166
_version_ 1783387856810541056
author Zheng, Yang
Zhang, Yinxi
Cai, Mengting
Lai, Nanxi
Chen, Zhong
Ding, Meiping
author_facet Zheng, Yang
Zhang, Yinxi
Cai, Mengting
Lai, Nanxi
Chen, Zhong
Ding, Meiping
author_sort Zheng, Yang
collection PubMed
description Objective: To provide a comprehensive review of the central nervous system (CNS) involvement in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), including the pathogenesis, clinical manifestations, ancillary investigations, differential diagnosis, and treatment. Particular emphasis is placed on the clinical spectrum and diagnostic testing of AAV. Recent Findings: AAV is a pauci-immune small-vessel vasculitis characterized by neutrophil-mediated vasculitis and granulomatousis. Hypertrophic pachymeninges is the most frequent CNS presentation. Cerebrovascular events, hypophysitis, posterior reversible encephalopathy syndrome (PRES) or isolated mass lesions may occur as well. Spinal cord is rarely involved. In addition, ear, nose and throat (ENT), kidney and lung involvement often accompany or precede the CNS manifestations. Positive ANCA testing is highly suggestive of the diagnosis, with each ANCA serotype representing different groups of AAV patients. Pathological evidence is the gold standard but not necessary. Once diagnosed, prompt initiation of induction therapy, including steroid and other immunosuppressants, can greatly mitigate the disease progression. Conclusions and Relevance: Early recognition of AAV as the underlying cause for various CNS disorders is important for neurologists. Ancillary investigations especially the ANCA testing can provide useful information for diagnosis. Future studies are needed to better delineate the clinical spectrum of CNS involvement in AAV and the utility of ANCA serotype to classify those patients. Evidence Review: We searched Pubmed for relevant case reports, case series, original research and reviews in English published between Sep 1st, 2001 and Sep 1st, 2018. The following search terms were used alone or in various combinations: “ANCA,” “proteinase 3/PR3-ANCA,” “myeloperoxidase/MPO-ANCA,” “ANCA-associated vasculitis,” “Wegener's granulomatosis,” “microscopic polyangiitis,” “Central nervous system,” “brain” and “spinal cord”. All articles identified were full-text papers.
format Online
Article
Text
id pubmed-6335277
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63352772019-01-25 Central Nervous System Involvement in ANCA-Associated Vasculitis: What Neurologists Need to Know Zheng, Yang Zhang, Yinxi Cai, Mengting Lai, Nanxi Chen, Zhong Ding, Meiping Front Neurol Neurology Objective: To provide a comprehensive review of the central nervous system (CNS) involvement in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), including the pathogenesis, clinical manifestations, ancillary investigations, differential diagnosis, and treatment. Particular emphasis is placed on the clinical spectrum and diagnostic testing of AAV. Recent Findings: AAV is a pauci-immune small-vessel vasculitis characterized by neutrophil-mediated vasculitis and granulomatousis. Hypertrophic pachymeninges is the most frequent CNS presentation. Cerebrovascular events, hypophysitis, posterior reversible encephalopathy syndrome (PRES) or isolated mass lesions may occur as well. Spinal cord is rarely involved. In addition, ear, nose and throat (ENT), kidney and lung involvement often accompany or precede the CNS manifestations. Positive ANCA testing is highly suggestive of the diagnosis, with each ANCA serotype representing different groups of AAV patients. Pathological evidence is the gold standard but not necessary. Once diagnosed, prompt initiation of induction therapy, including steroid and other immunosuppressants, can greatly mitigate the disease progression. Conclusions and Relevance: Early recognition of AAV as the underlying cause for various CNS disorders is important for neurologists. Ancillary investigations especially the ANCA testing can provide useful information for diagnosis. Future studies are needed to better delineate the clinical spectrum of CNS involvement in AAV and the utility of ANCA serotype to classify those patients. Evidence Review: We searched Pubmed for relevant case reports, case series, original research and reviews in English published between Sep 1st, 2001 and Sep 1st, 2018. The following search terms were used alone or in various combinations: “ANCA,” “proteinase 3/PR3-ANCA,” “myeloperoxidase/MPO-ANCA,” “ANCA-associated vasculitis,” “Wegener's granulomatosis,” “microscopic polyangiitis,” “Central nervous system,” “brain” and “spinal cord”. All articles identified were full-text papers. Frontiers Media S.A. 2019-01-10 /pmc/articles/PMC6335277/ /pubmed/30687221 http://dx.doi.org/10.3389/fneur.2018.01166 Text en Copyright © 2019 Zheng, Zhang, Cai, Lai, Chen and Ding. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Zheng, Yang
Zhang, Yinxi
Cai, Mengting
Lai, Nanxi
Chen, Zhong
Ding, Meiping
Central Nervous System Involvement in ANCA-Associated Vasculitis: What Neurologists Need to Know
title Central Nervous System Involvement in ANCA-Associated Vasculitis: What Neurologists Need to Know
title_full Central Nervous System Involvement in ANCA-Associated Vasculitis: What Neurologists Need to Know
title_fullStr Central Nervous System Involvement in ANCA-Associated Vasculitis: What Neurologists Need to Know
title_full_unstemmed Central Nervous System Involvement in ANCA-Associated Vasculitis: What Neurologists Need to Know
title_short Central Nervous System Involvement in ANCA-Associated Vasculitis: What Neurologists Need to Know
title_sort central nervous system involvement in anca-associated vasculitis: what neurologists need to know
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335277/
https://www.ncbi.nlm.nih.gov/pubmed/30687221
http://dx.doi.org/10.3389/fneur.2018.01166
work_keys_str_mv AT zhengyang centralnervoussysteminvolvementinancaassociatedvasculitiswhatneurologistsneedtoknow
AT zhangyinxi centralnervoussysteminvolvementinancaassociatedvasculitiswhatneurologistsneedtoknow
AT caimengting centralnervoussysteminvolvementinancaassociatedvasculitiswhatneurologistsneedtoknow
AT lainanxi centralnervoussysteminvolvementinancaassociatedvasculitiswhatneurologistsneedtoknow
AT chenzhong centralnervoussysteminvolvementinancaassociatedvasculitiswhatneurologistsneedtoknow
AT dingmeiping centralnervoussysteminvolvementinancaassociatedvasculitiswhatneurologistsneedtoknow